According to Mark Fainaru-Wada and T.J. Quinn of ESPN.com, Brewers outfielder Ryan Braun has tested positive for a performance-enhancing drug.

Braun, who won the 2011 National League MVP Award, is disputing the result through arbitration. If it is upheld, he will face a 50-game suspension.

It should be noted that Major League Baseball has not once overturned the result of a PED test.

Here’s more from Fainaru-Wada and Quinn, who revealed the stunning news on Saturday evening as part of an “Outside the Lines” investigation:

The 28-year-old Braun had to provide a urine sample for testing during the playoffs, and he was notified of the positive test sometime in late October — about a month before he was named the National League’s most valuable player.

The positive result was triggered by elevated levels of testosterone in Braun’s system, the sources also told “Outside the Lines.” A subsequent, more comprehensive test revealed the testosterone was synthetic — not produced by Braun’s body.

Braun, 28, batted .332 with a .994 OPS, 33 home runs and 111 RBI in 150 games this year. He posted an .866 OPS and hit only 25 home runs in 2010, somewhat of a down season for the slugging left fielder.

The Brewers signed Braun to a five-year, $105 million contract extension in April, adding to a previous eight-year pact that he inked with Milwaukee in May of 2008. He’s under team control through 2021.

Former Mets catcher Johnny Monell signed a contract with the KT Wiz of the Korea Baseball Organization, per a report by Chris Cotillo of SB Nation. The 30-year-old originally struck a deal with the NC Dinos on Thursday, but the deal appeared to fall through at the last minute, according to Cotillo’s unnamed source.

Monell last surfaced for the Mets during their 2015 run, batting a dismal .167/.231/.208 with two extra bases in 52 PA before the club DFA’d him to clear space for Bartolo Colon. While he’s had difficulty sticking at the major league level, he’s found a higher degree of success in the minor league circuit and holds a career .271 average over a decade of minor league play. He played exclusively in Triple-A Las Vegas during the 2016 season, slashing .276/.336/.470 with 19 home runs and a career-high 75 RBI in 461 PA.

The veteran backstop appears to be the second MLB player to join the KT Wiz roster this offseason, as right-hander Donn Roach also signed with the club last month on a one-year, $850,000 deal.

Brewers’ right-hander Phil Bickford received a 50-game suspension after testing positive for a drug of abuse, per the Los Angeles Times’ Bill Shaikin. This is the second time Bickford has been suspended for recreational drug use, as he was previously penalized in 2015 after testing positive for marijuana prior to the amateur draft.

Bickford was selected by the Giants in the first round of the 2015 draft and was later dealt to the Brewers for lefty reliever Will Smith at the 2016 trade deadline. He finished his 2016 campaign in High-A Brevard County, pitching to a 3.67 ERA, 10.0 K/9 rate and 5.0 BB/9 over 27 innings.

Two other suspensions were handed down on Friday, one to Toronto minor league right-hander Pedro Loficial for a positive test for metabolites of Stanozolol and one to Miami minor league outfielder Casey Soltis for a second positive test for drugs of abuse. Loficial will serve a 72-game suspension, while Soltis will serve 50 games. All three suspensions are due to start at the beginning of the 2017 season for each respective minor league team.

We are very disappointed to learn of Phil’s suspension, but we fully support the Minor League Baseball Drug Prevention and Testing Program and its enforcement by the Commissioner’s Office. Phil understands he made a mistake, and we fully anticipate that he will learn from this experience.